These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7541394)

  • 1. Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma.
    Söderström KO; Laato M; Wu P; Hopsu-Havu VK; Nurmi M; Rinne A
    Int J Cancer; 1995 Jul; 62(1):1-4. PubMed ID: 7541394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
    Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO
    Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.
    Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI
    Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical study of the prostatic tissues with monoclonal antibody against gamma-seminoprotein. Analyses of benign prostatic hyperplasia, metastatic foci from adenocarcinoma of the prostate and malignant neoplasms other than adenocarcinoma of the prostate].
    Fujino A; Shimura S; Murayama M; Ao T; Yokoyama E; Mashimo S; Ishibashi A; Koshiba K; Kuwao S
    Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):527-34. PubMed ID: 7685842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis.
    Sinha AA; Jamuar MP; Wilson MJ; Rozhin J; Sloane BF
    Prostate; 2001 Nov; 49(3):172-84. PubMed ID: 11746262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
    Maygarden SJ; Strom S; Ware JL
    Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
    Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
    Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of acid cysteine proteinase inhibitor (cystatin A) in the human thymus.
    Söderström KO; Rinne R; Hopsu-Havu VK; Järvinen M; Rinne A
    Anat Rec; 1994 Sep; 240(1):115-9. PubMed ID: 7529009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.
    Leinonen T; Pirinen R; Böhm J; Johansson R; Rinne A; Weber E; Kosma VM
    J Clin Pathol; 2007 May; 60(5):515-9. PubMed ID: 16790691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma.
    Djonov V; Ball RK; Graf S; Mottaz AE; Arnold AM; Flanders K; Studer UE; Merz VW
    Prostate; 1997 May; 31(2):103-9. PubMed ID: 9140123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining of ras p21: staining in benign and malignant prostate tissue.
    Bushman EC; Nayak RN; Bushman W
    J Urol; 1995 Jan; 153(1):233-7. PubMed ID: 7526005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia.
    Bentley H; Hamdy FC; Hart KA; Seid JM; Williams JL; Johnstone D; Russell RG
    Br J Cancer; 1992 Dec; 66(6):1159-63. PubMed ID: 1280991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Prostate; 2001 Sep; 48(4):274-84. PubMed ID: 11536307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 is not detected on human prostate cancer cells by immunohistologic techniques.
    Moghaddami M; Cohen P; Stapleton AM; Brown MP
    Urology; 2001 Mar; 57(3):573-8. PubMed ID: 11248650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.
    Hamdy FC; Autzen P; Robinson MC; Horne CH; Neal DE; Robson CN
    Cancer Res; 1997 Oct; 57(19):4427-31. PubMed ID: 9331107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Arenas MI; Romo E; de Gaspar I; de Bethencourt FR; Sánchez-Chapado M; Fraile B; Paniagua R
    Glycoconj J; 1999 Jul; 16(7):375-82. PubMed ID: 10619710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid cysteine proteinase inhibitor in cutaneous lymphocytic infiltrates.
    Aho HJ; Ping W; Söderström KO; Rinne A; Rinne R; Hopsu-Havu VK
    Am J Dermatopathol; 1995 Apr; 17(2):115-25. PubMed ID: 8600775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.